JPMorgan Chase & Co’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Buy |
|
|||||
|
2024
Q4 | $2.49M | Sell |
|
|||||
|
2024
Q3 | $3.56M | Sell |
|
|||||
|
2024
Q2 | $1.28M | Sell |
|
|||||
|
2024
Q1 | $1.03M | Sell |
|
|||||
|
2023
Q4 | $773K | Buy |
|
|||||
|
2023
Q3 | $400K | Buy |
|
|||||
|
2023
Q2 | $292K | Buy |
|
|||||
|
2023
Q1 | $40K | Buy |
|
|||||
|
2022
Q4 | $58K | Buy |
|
|||||
|
2022
Q3 | $15K | Buy |
|
|||||
|
2022
Q2 | $6K | Sell |
|
|||||
|
2022
Q1 | $58K | Sell |
|
|||||
|
2021
Q4 | $90K | Buy |
|
|||||
|
2021
Q3 | $85K | Sell |
|
|||||
|
2021
Q2 | $128K | Sell |
|
|||||
|
2021
Q1 | $142K | Sell |
|
|||||
|
2020
Q4 | $2.32M | Sell |
|
|||||
|
2020
Q3 | $5.48M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $34K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $84K | Buy |
|
|||||
|
2017
Q4 | $11K | Buy |
|